Literature DB >> 18200655

What's new in inflammatory bowel disease in 2008?

Daniel C Baumgart1.   

Abstract

Ulcerative colitis and Crohn's disease represent the two major forms of inflammatory bowel disease. In this highlight topic series of articles we cover the latest developments in genetics and epidemiology, intestinal physiology, mucosal immunology, mechanisms of epithelial cell injury and restitution, current medical therapy, modern surgical management, important extra-intestinal complications such as primary sclerosing cholangitis, cholangiocellular carcinoma and autoimmune hepatitis as well as endoscopic and molecular screening, detection and prevention of small bowel and colorectal cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18200655      PMCID: PMC2679121          DOI: 10.3748/wjg.14.329

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

1.  WILHELM FABRY (1560-1624)--THE OTHER FABRICIUS.

Authors: 
Journal:  JAMA       Date:  1964-12-07       Impact factor: 56.272

Review 2.  Role of the intestinal barrier in inflammatory bowel disease.

Authors:  Mike G Laukoetter; Porfirio Nava; Asma Nusrat
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 3.  Immunopathogenesis of inflammatory bowel disease.

Authors:  David Q Shih; Stephan R Targan
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 4.  Recent trends in the surgical management of inflammatory bowel disease.

Authors:  Robert E Roses; John L Rombeau
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

5.  Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer.

Authors:  B B Crohn; L Ginzburg; G D Oppenheimer
Journal:  JAMA       Date:  1984-01-06       Impact factor: 56.272

Review 6.  Special issues in pediatric inflammatory bowel disease.

Authors:  Marla Dubinsky
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 7.  Cancer in inflammatory bowel disease.

Authors:  Jianlin Xie; Steven H Itzkowitz
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 8.  Inflammatory bowel disease: genetic and epidemiologic considerations.

Authors:  Judy H Cho
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 9.  Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

Authors:  Rebecca Saich; Roger Chapman
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 10.  Epithelial restitution and wound healing in inflammatory bowel disease.

Authors:  Andreas Sturm; Axel U Dignass
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

View more
  6 in total

1.  Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?

Authors:  Rebekka Mueller; Farah Ziade; Valérie Pittet; Nicolas Fournier; Jessica Ezri; Alain Schoepfer; Susanne Schibli; Johannes Spalinger; Christian Braegger; Andreas Nydegger
Journal:  J Crohns Colitis       Date:  2015-10-29       Impact factor: 9.071

2.  Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer.

Authors:  Beatriz Pagán; Angel A Isidro; Domenico Coppola; Zhengming Chen; Yuan Ren; Jie Wu; Caroline B Appleyard
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

3.  Is lymphatic status related to regression of inflammation in Crohn's disease?

Authors:  Francesco Tonelli; Francesco Giudici; Gadiel Liscia
Journal:  World J Gastrointest Surg       Date:  2012-10-27

4.  Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity.

Authors:  Anastassios C Manolakis; Andreas N Kapsoritakis; Anastasia Kapsoritaki; Elisavet K Tiaka; Konstantinos A Oikonomou; Vassilis Lotis; Dimitra Vamvakopoulou; Ioanna Davidi; Nikolaos Vamvakopoulos; Spyros P Potamianos
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

5.  A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.

Authors:  Lin Deng; Jin-Feng Zhou; Rani S Sellers; Jiu-Feng Li; Andrew V Nguyen; Yubao Wang; Amos Orlofsky; Qiang Liu; David A Hume; Jeffrey W Pollard; Leonard Augenlicht; Elaine Y Lin
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

Review 6.  New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance.

Authors:  Kartikeya Tripathi; Joseph D Feuerstein
Journal:  Drugs Context       Date:  2019-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.